001     143807
005     20240229112608.0
024 7 _ |a 10.1016/j.psyneuen.2019.03.019
|2 doi
024 7 _ |a pmid:30954921
|2 pmid
024 7 _ |a 0306-4530
|2 ISSN
024 7 _ |a 1873-3360
|2 ISSN
024 7 _ |a altmetric:58069415
|2 altmetric
037 _ _ |a DKFZ-2019-01369
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Grund, Thomas
|b 0
245 _ _ |a Chemogenetic activation of oxytocin neurons: Temporal dynamics, hormonal release, and behavioral consequences.
260 _ _ |a Amsterdam [u.a.]
|c 2019
|b Elsevier Science
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1559650387_6511
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Chemogenetics provides cell type-specific remote control of neuronal activity. Here, we describe the application of chemogenetics used to specifically activate oxytocin (OT) neurons as representatives of a unique class of neuroendocrine cells. We injected recombinant adeno-associated vectors, driving the stimulatory subunit hM3Dq of a modified human muscarinic receptor into the rat hypothalamus to achieve cell type-specific expression in OT neurons. As chemogenetic activation of OT neurons has not been reported, we provide systematic analysis of the temporal dynamics of OT neuronal responses in vivo by monitoring calcium fluctuations in OT neurons, and intracerebral as well as peripheral release of OT. We further provide evidence for the efficiency of chemogenetic manipulation at behavioral levels, demonstrating that evoked activation of OT neurons leads to social motivation and anxiolysis. Altogether, our results will be profitable for researchers working on the physiology of neuroendocrine systems, peptidergic modulation of behaviors and translational psychiatry.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Tang, Yan
|0 P:(DE-He78)d821e448212defd91ac1e67f9653a34d
|b 1
|u dkfz
700 1 _ |a Benusiglio, Diego
|0 P:(DE-He78)a1d6cc139b384a5a74e91e16881a0acd
|b 2
|u dkfz
700 1 _ |a Althammer, Ferdinand
|0 P:(DE-He78)c85332431993c88d28132a54566150ef
|b 3
|u dkfz
700 1 _ |a Probst, Sophia
|b 4
700 1 _ |a Oppenländer, Lena
|b 5
700 1 _ |a Neumann, Inga D
|b 6
700 1 _ |a Grinevich, Valery
|0 P:(DE-He78)b2142a2557ce071790760d0126e259d3
|b 7
|e Last author
|u dkfz
773 _ _ |a 10.1016/j.psyneuen.2019.03.019
|g Vol. 106, p. 77 - 84
|0 PERI:(DE-600)1500706-6
|p 77 - 84
|t Psychoneuroendocrinology
|v 106
|y 2019
|x 0306-4530
909 C O |o oai:inrepo02.dkfz.de:143807
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)d821e448212defd91ac1e67f9653a34d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)a1d6cc139b384a5a74e91e16881a0acd
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)c85332431993c88d28132a54566150ef
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b2142a2557ce071790760d0126e259d3
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2019
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b PSYCHONEUROENDOCRINO : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)V078-20160331
|k V078
|l AG Neuropeptide
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)V078-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21